VERA News and Press, Vera Therapeutics Inc. From 08/10/23

Presented positive 36-week results from the Phase 2b ORIGIN clinical trial of atacicept in IgAN as a late breaking clinical trial at the 60 th ERA Congress Initiated Phase 3 ORIGIN 3 clinical trial of atacicept in June for the treatment of IgAN Strong balance sheet e...

2023-07-04 09:42:14 ET Summary Vera Therapeutics revealed 36-week efficacy and safety findings of its Phase IIb ORIGIN clinical study of atacicept for IgAN at the 60th European Renal Association Congress. The study met its primary and secondary objectives, showing significant redu...

2023-07-03 13:39:25 ET Summary Vera Therapeutics, Inc. is trying to develop an old molecule it licensed from Merck & Co., Inc. Trials conducted years earlier produced unimpressive results. While the company has produced some positive data, I am not convinced yet. ...

2023-06-20 19:04:10 ET Shares of Vera Therapeutics (NASDAQ: VERA) closed 16.9% higher on Tuesday after jumping as much as 23.5%. The clinical-stage biotech company announced positive news regarding trial results for one of its therapies. The stock is up more than 100% over the p...

2023-06-20 09:33:57 ET If you're looking for stocks that can make dramatic moves to the upside in a short amount of time, the biopharmaceutical industry has you covered. Over the past month, shares of Chinook Therapeutics (NASDAQ: KDNY) and Vera Therapeutics (NASDAQ: VERA) h...

New data at week 36 shows atacicept 150 mg resulted in a delta of 43% versus placebo in mean proteinuria reduction in per-protocol analysis and demonstrated statistically significant stabilization of eGFR versus placebo in this high-risk population Atacicept was well tolerated with safe...

BRISBANE, Calif., June 15, 2023 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced it will host a post-ERA data present...

2023-06-14 13:15:45 ET Gainers: WeTrade Group ( WETG ) +81% . SEALSQ Corp ( LAES ) +81% . Greenidge Generation Holdings ( GREE ) +49% . NextDecade Corporation ( NEXT ) +45% . WiSA Technologies ( WISA ) +31% . Vera Therapeutic...

2023-06-13 17:41:09 ET Gainers: Inventiva ( IVA ) +42% . NOVONIX  ( NVX ) +5% . EyePoint Pharmaceuticals ( EYPT ) +5% . 908 Devices  ( MASS ) +5% . Vera Therapeutics ( VERA ) +5% . Losers: Microvision ( MVIS ...

2023-06-12 12:05:53 ET Shares of Vera Therapeutics (NASDAQ: VERA) were up more than 18.8% Monday morning, after climbing as high as 25% shortly after the market opened. The healthcare stock 's move was likely triggered after one competitor with a similar lead therapy saw positiv...